Use of national guidelines for the introduction of Drotrecogin alfa (activated)

類似資料

• Audit of adherence to National Institute of Clinical Excellence guidelines for the use of drotrecogin alfa (activated)
  著者:: Vedantham, R, 等
  出版事項: (2007)
• Increasing microcirculation after drotrecogin alfa (activated)
  著者:: Donati, A, 等
  出版事項: (2007)
• Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
  著者:: Beale, R, 等
  出版事項: (2007)
• A large, single-centre UK registry of drotrecogin alfa-activated use
  著者:: Macchiavello, L, 等
  出版事項: (2007)
• Drotrecogin alfa (activated) does not impair platelet receptor expression in vitro
  著者:: Schuerholz, T, 等
  出版事項: (2004)